ArticleFrontiers in oncology2023

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study.

Weili Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.